EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Cytosolic EZH2-IMPDH2 complexes regulate melanoma progression and metastasis via GTP

Gamze Kuser-Abali, Fumihito Noguchi, Peinan Zhao, Pacman Szeto, Youfang Zhang, Cheng Huang, Christopher K Barlow, Giovanna Pomilio, Marion Boudes, Christopher Chew, Samar Masoumi Moghaddam, Isobel Leece und 9 weitere

Molecular Cell · 2026

DOI: 10.1016/j.molcel.2026.06.003 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Cell, 2026. Verfasst von Gamze Kuser-Abali und 20 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cancer Medicine, Monash University, Melbourne, VIC 3004, Australia. Hauptthemen laut MEDLINE: Enhancer of Zeste Homolog 2 Protein, IMP Dehydrogenase, Melanoma, Guanosine Triphosphate. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 105 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Victorian Cancer Agency, National Health and Medical Research Council, CASS Foundation Ltd.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Enhancer of zeste homolog 2 (EZH2) is a methyltransferase that tri-methylates histone H3K27 as the catalytic subunit of the polycomb repressive complex 2. However, inhibition of EZH2 methyltransferase showed only variable anti-cancer efficacy, suggesting that this approach is insufficient. Here, we demonstrate a methyltransferase-independent mechanism of EZH2 wherein EZH2 interacts with inosine monophosphate dehydrogenase 2 (IMPDH2) in the cytoplasm to promote guanosine-5'-triphosphate (GTP) synthesis. Mass spectrometry identified methyltransferase-independent interactions between the EED-binding domain of EZH2 and the CBS domain of IMPDH2. EZH2 knockdown impeded IMPDH2 and reduced GTP levels, ribosome biogenesis, and cancer progression-effects reversed by guanosine. IMPDH2 knockout antagonized EZH2's tumor-promoting effects in vivo, and increased cytosolic EZH2 and IMPDH2 expression was observed in human melanomas and associated with nucleolar enlargement. EZH2-IMPDH2 complexes were also observed across multiple cancers, wherein Sappanone A (SA), which inhibits EZH2-IMPDH2 interactions, was anti-tumorigenic. These findings reveal a methyltransferase-independent oncogenic mechanism of EZH2.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Enhancer of Zeste Homolog 2 ProteinIMP DehydrogenaseMelanomaGuanosine TriphosphateHumansAnimalsCell Line, TumorDisease ProgressionCytosolNeoplasm MetastasisGene Expression Regulation, NeoplasticCell MovementMiceCell Proliferation

Stichwörter der Autor:innen

EZH2GTP metabolismIMPDH2Sappanone Aactomyosin contractilitycancercell motilitycell proliferationmelanomaribosome biogenesis

Substanzen

Enhancer of Zeste Homolog 2 ProteinIMP DehydrogenaseIMPDH2 protein, humanEZH2 protein, humanGuanosine Triphosphate

Autor:innen und Institutionen

  • Department of Cancer Medicine, Monash University, Melbourne, VIC 3004, Australia.
  • Department of Cancer Medicine, Monash University, Melbourne, VIC 3004, Australia; Department of Oncology, Alfred Health, Melbourne, VIC 3004, Australia.
  • Monash Proteomics and Metabolomics Facility, Monash University, Clayton, VIC 3800, Australia.
  • Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC 3004, Australia.
  • Department of Biochemistry and Molecular Biology, Biomedicine Discovery Institute, Monash University, Clayton, VIC 3800, Australia.
  • Department of Cancer Medicine, Monash University, Melbourne, VIC 3004, Australia; Department of Oncology, Alfred Health, Melbourne, VIC 3004, Australia. Electronic address: mark.shackleton@monash.edu.

Förderung

  • Victorian Cancer Agency
  • National Health and Medical Research Council
  • CASS Foundation Ltd
  • Melanoma Research Alliance

Zitieren

APA

Kuser-Abali, G., Noguchi, F., Zhao, P., Szeto, P., Zhang, Y., Huang, C., Barlow, C. K., Pomilio, G., Boudes, M., Chew, C., Moghaddam, S. M., Leece, I., Cheung, J. G., Ameratunga, M., Wong, N. C., Andrews, M. C., Schittenhelm, R. B., Wei, A., Naranbhai, V., …, & Shackleton, M. (2026). Cytosolic EZH2-IMPDH2 complexes regulate melanoma progression and metastasis via GTP. Molecular Cell. https://doi.org/10.1016/j.molcel.2026.06.003

Vancouver

Kuser-Abali G, Noguchi F, Zhao P, Szeto P, Zhang Y, Huang C, et al. Cytosolic EZH2-IMPDH2 complexes regulate melanoma progression and metastasis via GTP. Molecular Cell. 2026. doi:10.1016/j.molcel.2026.06.003

BibTeX
@article{KuserAbali2026,
  author = {Kuser-Abali, Gamze and Noguchi, Fumihito and Zhao, Peinan and Szeto, Pacman and Zhang, Youfang and Huang, Cheng and Barlow, Christopher K and Pomilio, Giovanna and Boudes, Marion and Chew, Christopher and Moghaddam, Samar Masoumi and Leece, Isobel and Cheung, Jen G and Ameratunga, Malaka and Wong, Nicholas C and Andrews, Miles C and Schittenhelm, Ralf B and Wei, Andrew and Naranbhai, Vivek and Davidovich, Chen and Shackleton, Mark},
  title = {Cytosolic EZH2-IMPDH2 complexes regulate melanoma progression and metastasis via GTP},
  journal = {Molecular Cell},
  year = {2026},
  doi = {10.1016/j.molcel.2026.06.003}
}
Kostenlos starten →